Spinal Pumps Market (2026 - 2033)

Spinal Pumps Market Summary

The global spinal pumps market size was valued at USD 353.3 million in 2025 and is projected to grow from USD 361.1 million in 2026 to USD 416.9 million by 2033, at a CAGR of 2.0% from 2026 to 2033. North America dominated the market, accounting for the largest revenue share in 2025. The market is expected to surge due to several factors: increasing cases of movement disorders and chronic pain, a growing elderly population at risk for these conditions, and advancements in spinal pump technology driven by rising R&D investment.

Source: Grand View Research, IR Documents, Primary Interviews, Paid Databases

To learn more about this report, Download Free Sample Report

Manufacturers are increasingly focusing on developing next-generation implantable drug delivery systems that offer improved reliability, cybersecurity, and dosing precision to enhance patient outcomes. For instance, in April 2024, Bux Pain Management launched SynchroMed III, a U.S. Food and Drug Administration (FDA)-approved intrathecal drug delivery system for cancer pain, chronic pain, and severe spasticity. This innovative technology promises significant progress in pain management therapy.

The rapidly expanding geriatric population is another significant factor supporting market growth. Older adults are at a higher risk of developing degenerative spinal disorders, chronic pain, Parkinson's disease, and other neurological conditions that often require long-term pain management therapies. For instance, in October 2025, according to the World Health Organization, globally, 1 in 6 people will be aged 60 years or older by 2030, with the global population in this age group projected to reach 2.1 billion, creating sustained demand for implantable pain management technologies.

Analyst Perspective

The spinal pumps industry is experiencing steady growth, driven by the increasing prevalence of chronic pain and neurological disorders, rising demand for targeted drug delivery systems, and growing adoption of minimally invasive pain management therapies. Spinal pumps are gaining favor as a means for healthcare practitioners to deliver the appropriate amount of medication directly into the intrathecal space, thereby improving outcomes and reducing adverse effects in people with chronic pain, spasticity, and other neurological diseases. An increase in the number of older adults, more cases of spinal cord injury, and a preference for customized treatment are additional factors fueling growth in this market. Technological innovations are also expected to increase treatment reliability and patient safety. As demand for effective, minimally invasive, and patient-centric drug delivery solutions continues to rise, companies that invest in technology and research will be well-positioned to grow in this market.

Product Insights

The implantable pump with continuous flow segment led the market with the largest revenue share of around 60.0% in 2025. The segment's dominance is attributed to the widespread adoption of continuous intrathecal drug delivery systems for the long-term management of chronic pain, cancer pain, and severe spasticity. These pumps provide consistent medication delivery, improving symptom control, reducing systemic drug exposure, and enhancing patient compliance.

Technological advancements focused on improving device safety, programmability, and reliability are further supporting market growth. For instance, in January 2024, Nura Pain Clinics became the first healthcare provider in Minnesota to implement Medtronic’s SynchroMed III targeted drug delivery system for the treatment of chronic pain. The procedure marked the initial commercial adoption of Medtronic’s next-generation implantable intrathecal pump following its U.S. Food and Drug Administration (FDA) approval, highlighting continued advancements in targeted pain management technologies.

The implantable pump with bolus-variable flow segment is expected to grow at the fastest CAGR during the forecast period. Growth is driven by increasing demand for personalized drug delivery, allowing clinicians to program variable dosing schedules based on patient requirements. These systems improve pain management while minimizing adverse effects and optimizing therapeutic outcomes. Growing research into programmable intrathecal delivery platforms is expected to further support segment growth.

Application Insights

The pain management segment led the market with the largest revenue share of around 70.0% in 2025, driven by the rising prevalence of chronic pain conditions and the growing demand for long-term, targeted pain management therapies. Intrathecal drug delivery systems provide effective pain control while reducing opioid consumption and systemic side effects, making them a preferred treatment option for patients with refractory chronic pain.

The spasticity management segment is expected to grow at the fastest CAGR during the forecast period. The increasing prevalence of neurological disorders such as cerebral palsy, multiple sclerosis, traumatic brain injury, and spinal cord injury is driving demand for intrathecal baclofen therapy. Implantable spinal pumps offer sustained drug delivery, improving muscle tone, mobility, and quality of life for patients with severe spasticity.

End Use Insights

The hospitals segment led the market with the largest revenue share of over 60.0% in 2025. Hospitals remain the primary setting for spinal pump implantation because they provide multidisciplinary expertise, advanced imaging capabilities, neurosurgical support, and comprehensive postoperative care. The increasing availability of specialized pain management and neurosurgical centers continues to support the adoption of implantable intrathecal drug delivery systems.

The outpatient facilities segment is anticipated to grow at the fastest CAGR during the forecast period. Increasing preference for minimally invasive procedures, improved follow-up care, and reduced healthcare costs are driving the transition toward outpatient settings. These facilities play an essential role in routine pump programming, medication refills, device monitoring, and early detection of pump-related complications, improving long-term patient outcomes.

Regional Insights

North America dominated the global spinal pumps market with the largest revenue share in 2025. It is attributable to increasing spending on research and development in the region for chronic pain management.

U.S. Spinal Pumps Market Trends

The spinal pumps market in the U.S. accounted for the largest market revenue share of around 90.0% in North America in 2025, due to the country's high demand for spinal pumps. Moreover, the rising prevalence of chronic pain conditions among U.S. adults is expected to boost the market. For instance, in January 2025, according to the National Spinal Cord Injury Statistical Center (NSCISC) Facts and Figures at a Glance, approximately 18,000 new traumatic spinal cord injury (TSCI) cases occur annually in the U.S. The growing incidence of spinal cord injuries is increasing the need for advanced long-term pain and spasticity management therapies, including intrathecal drug delivery systems (spinal pumps), thereby supporting market growth.

Europe Spinal Pumps Market Trends

The spinal pumps market in Europe is anticipated to grow at a lucrative CAGR during the forecast period, driven by rising cases of neuropathic pain. For instance, according to a systematic review published in the journal PAIN in October 2024, the prevalence of chronic pain among European adults ranged from 12% to 48%, depending on the population and diagnostic criteria used. The review also identified female sex, older age, lower educational attainment, unemployment, medical comorbidities, mental health disorders, and functional impairment as key factors associated with chronic pain, highlighting the growing need for effective long-term pain management solutions across Europe.

The UK spinal pumps market is expected to grow rapidly during the forecast period, due to rapid population aging. For instance, according to the Health Survey for England published by NHS England in January 2026, 26% of adults reported chronic pain, while 13% experienced high-impact chronic pain that frequently limited daily activities. The prevalence increased substantially with age and was higher among women, supporting the growing demand for advanced chronic pain management therapies.

The spinal pumps market in Germany held a substantial market share in Europe in 2025, due to the country's increasing prevalence of back and neck pain. For instance, a review published in Frontiers in Pain Research in September 2025 reported that approximately 25% to 32% of adults in Germany seek healthcare for low back pain annually. The review also found increasing hospital admissions, spinal surgeries, and opioid use associated with low back pain, highlighting the growing burden of spinal disorders and the need for advanced treatment options.

Asia Pacific Spinal Pumps Market Trends

The spinal pumps market in the Asia Pacific is anticipated to grow at the fastest CAGR during the forecast period. This growth is due to the region's high prevalence of patients with chronic pain.

The Japan spinal pumps market is expected to grow rapidly during the forecast period, due to the increasing demand for intrathecal pumps in the forecasted period. The recent advancement in intrathecal drug delivery of opioids or other analgesics for the treatment of multiple sclerosis-associated pain and other neurological pain drives the market.

The spinal pumps market in China held a substantial market share in the Asia Pacific in 2025, due to increased intrathecal pump usage in treating cancer-associated pain.

Latin America Spinal Pumps Market Trends

The spinal pumps market in Latin America is anticipated to grow at a significant CAGR over the forecast period. Collaborations and investments from major industry leaders drive the market, as does the regulatory approval of intrathecal pumps for the treatment of chronic to moderate pain in the region.

The Brazil spinal pump market held a substantial market share in Latin America in 2025 and is expected to grow at a significant CAGR during the forecast period, as chronic pain is highly prevalent in the Country.

Middle East & Africa Spinal Pumps Market Trends

The spinal pumps market in the Middle East and Africa is anticipated to grow significantly over the forecast period, owing to the rising prevalence of chronic conditions in the region, as these devices offer effective pain management solutions for conditions such as chronic back pain, cancer pain, and spasticity.

The South Africa spinal pump market had a substantial market share in the Middle East and Africa in 2025. The high demand for spinal pumps in the treatment of neuropathic pain has rapidly driven the growth of the South Africa spinal pumps over the forecast period. The African population experiences neuropathic pain because of the unavailability of essential nutrients.

Key Spinal Pumps Company Insights

Some of the key companies in the spinal pumps industry include Medtronic, DePuy Synthes (Medical Device Business Services, Inc.), Teleflex Incorporated, Smiths Group plc, FLOWONIX MEDICAL INC, Tricumed Medical Technology GmbH, Baxter, Globus Medical, DAIICHI SANKYO COMPANY, LIMITED., and Stryker. Organizations are focusing on increasing their customer base to gain a competitive edge in the industry. Therefore, key players are taking several strategic initiatives, such as mergers and acquisitions, and partnerships with other major companies.

• Medtronic is a medical technology company that creates, produces, and sells medical devices and solutions. It provides products to treat a wide range of health conditions, including coronary artery diseases, heart failure, peripheral vascular diseases, heart valve disorders, venous, renal, and neurological conditions, aortic conditions, spinal and musculoskeletal disorders, and ear, nose, and throat ailments. It additionally offers biological remedies for the orthopedic and dental sectors.
• Smith’s Group plc is a technology company with diversified operations. It offers vital solutions for energy and processing, medical devices and supplies, and devices for detecting and identifying security threats and contraband. It also offers answers for fast connection and parts for heating and transferring fluids and gases.

Key Spinal Pumps Companies

The following key companies have been profiled for this study on the global spinal pumps market.

• Medtronic

• Teleflex Incorporated

• Smith’s Group plc

• FLOWONIX MEDICAL INC

• Tricumed Medical Technology GmbH

• BD

• pfm medical gmbh

• Fresenius Kabi AG

• Micrel Medical Devices S.A.

• Codman & Shurtleff, Inc. (Integra LifeSciences)

Recent Developments

• In April 2025, researchers from the University of California, Los Angeles (UCLA) published a case series highlighting advances in intrathecal drug delivery systems, including improvements in surgical techniques, device safety, complication management, and cybersecurity considerations for programmable implantable pumps. The study emphasized the continued evolution of spinal pump technology to improve long-term clinical outcomes.

• In January 2024, Ontario Health published a comprehensive Health Technology Assessment evaluating intrathecal drug delivery systems (IDDS) for cancer pain. The assessment concluded that IDDS can improve pain control while reducing systemic opioid-related adverse effects in appropriately selected patients, supporting the adoption of implantable spinal pump therapy for refractory cancer pain.

Global Spinal Pumps Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global spinal pumps market report based on the product, application, end use, and region:

• Product Outlook (Revenue, USD Million, 2021 - 2033)

  • Implantable Pump with Continuous Flow

  • Implantable Pump with Bolus-variable Flow

• Application Outlook (Revenue, USD Million, 2021 - 2033)

  • Spasticity Management

  • Pain Management Machine Learning

    • Non-malignant Pain

    • Malignant Pain

• End Use Outlook (Revenue, USD Million, 2021 - 2033)

  • Hospitals

  • Outpatient Facilities

• Regional Outlook (Revenue, USD Million, 2021 - 2033)

  • North America

    • U.S.

    • Canada

    • Mexico

  • Europe

    • UK

    • Germany

    • France

    • Italy

    • Spain

    • Denmark

    • Sweden

    • Norway

  • Asia Pacific

    • Japan

    • China

    • India

    • Australia

    • South Korea

    • Thailand

  • Latin America

    • Brazil

    • Argentina

  • Middle East and Africa (MEA)

    • South Africa

    • Saudi Arabia

    • UAE

    • Kuwait